Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, and Ministry of Education (MOE) Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430030, PR China.
Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, Guangdong Province, 518051, PR China.
J Trace Elem Med Biol. 2021 Dec;68:126824. doi: 10.1016/j.jtemb.2021.126824. Epub 2021 Jul 28.
Hypertensive patients, often characterized by chronic inflammation, are susceptible to diabetes. Evidence suggests that the positive association between serum ferritin (SF) and diabetes was affected by high-sensitivity C-reactive protein (hs-CRP), an inflammation marker. We investigate whether there was an interaction between SF and hs-CRP on diabetes in hypertensive patients.
We analysed data of 1,735 hypertensive people in this cross-sectional study. Diabetes was diagnosed when fasting blood glucose ≥ 7.0 mmol/L and/or a previous clinical diagnosis of diabetes. Logistic regression models were used to estimate the association of the SF and hs-CRP with diabetes. Multiplicative interaction was evaluated by incorporating a cross-product term for SF and hs-CRP to the logistic regression model. Additive interaction was assessed by calculating the relative excess risk of interaction (RERI) and attributed proportion due to interaction (AP).
In the adjusted analysis, SF (highest vs lowest tertile: odds ratio [OR], 1.61; 95 % confidence interval [CI], 1.20-2.16) was positively associated with diabetes. There was no multiplicative interaction between SF and hs-CRP, but evidence of additive interaction in regard to diabetes (RERI: 0.86; 95 % CI: 0.06-1.67). Compared to the patients with low SF (lower two thirds) and low hs-CRP (≤ 2 mg/L), those with high SF (upper one third) and high hs-CRP (> 2 mg/L) had increased OR for diabetes (adjusted OR: 2.33 [1.65-3.30]), with 37.0 % of the effects attributed to the additive interaction (AP: 0.37; 95 % CI: 0.09-0.65).
Within a cross-sectional study consisting of hypertensive patients, co-exposure to high SF and high hs-CRP was synergistically associated with diabetes. Dietary intervention or pharmacological treatment to lowering SF concentration may help to reduce diabetes morbidity in hypertensive patient with chronic inflammation.
高血压患者常伴有慢性炎症,易患糖尿病。有证据表明,血清铁蛋白(SF)与糖尿病之间的正相关关系受到高敏 C 反应蛋白(hs-CRP)的影响,hs-CRP 是一种炎症标志物。我们研究了高血压患者中 SF 和 hs-CRP 之间是否存在与糖尿病的相互作用。
我们对这项横断面研究中的 1735 名高血压患者进行了数据分析。糖尿病的诊断标准为空腹血糖≥7.0mmol/L 和/或既往临床诊断为糖尿病。采用 logistic 回归模型估计 SF 和 hs-CRP 与糖尿病的相关性。通过将 SF 和 hs-CRP 的交叉乘积项纳入 logistic 回归模型,评估 SF 和 hs-CRP 之间的相乘交互作用。通过计算交互超额相对危险度(RERI)和归因于交互作用的比例(AP)来评估相加交互作用。
在调整后的分析中,SF(最高 vs 最低三分位:比值比 [OR],1.61;95 %置信区间 [CI],1.20-2.16)与糖尿病呈正相关。SF 和 hs-CRP 之间没有相乘交互作用,但在糖尿病方面存在相加交互作用的证据(RERI:0.86;95 %CI:0.06-1.67)。与低 SF(低三分位)和低 hs-CRP(≤2mg/L)的患者相比,SF 高(高三分位)和 hs-CRP 高(>2mg/L)的患者发生糖尿病的 OR 增加(调整 OR:2.33 [1.65-3.30]),其中 37.0 %的作用归因于相加交互作用(AP:0.37;95 %CI:0.09-0.65)。
在一项由高血压患者组成的横断面研究中,SF 和 hs-CRP 同时升高与糖尿病协同相关。降低 SF 浓度的饮食干预或药物治疗可能有助于降低伴有慢性炎症的高血压患者的糖尿病发病率。